Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Current Drug Delivery|February 4, 2017
Cholinergic Anti-inflammatory Pathway and StrokeKamil Duris, Jolana Lipkova, Michal JurajdaExperimental Neurology|December 2, 2023
Vagus nerve stimulation as immunomodulatory therapy for stroke: A comprehensive reviewMatyas Jelinek, Jolana Lipkova, Kamil DurisMolecular Immunology|July 4, 2012
RANTES, MCP-1 chemokines and factors describing rheumatoid arthritisMonika Pavkova Goldbergova, Jolana Lipkova, Nikolas Pavek, et al.Diabetes Research and Clinical Practice|July 2, 2010
Comparison of agouti-related peptide levels in peripheral blood of postpartum pre-eclamptic and non pre-eclamptic women and in umbilical cord blood from their pregnanciesJulie Bienertova-Vasku, Petr Bienert, Josef Tomandl, et al.Chronobiology International|May 29, 2014
Period3 VNTR polymorphism influences the time-of-day pain onset of acute myocardial infarction with ST elevationJolana Lipkova, Zbynek Splichal, Julie Anna Bienertova-Vasku, et al.Clinical and Experimental Medicine|June 18, 2014
Association of circulating levels of RANTES and -403G/A promoter polymorphism to acute heart failure after STEMI and to cardiogenic shockJolana Lipkova, Jiri Parenica, Kamil Duris, et al.Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|September 25, 2012
Circulating cytokine pattern and factors describing rheumatoid arthritis: IL-15 as one of the biomarkers for RA?Monika Pavkova Goldbergova, Nikolas Pavek, Jolana Lipkova, et al.Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|November 7, 2012
Per3 VNTR polymorphism and chronic heart failureJolana Lipkova, Julie Anna Bienertova-Vasku, Lenka Spinarova, et al.Journal of Applied Genetics|January 20, 2017
Relationship of long-term prognosis to MMP and TIMP polymorphisms in patients after ST elevation myocardial infarctionMonika Pavkova Goldbergova, Jiri Jarkovsky, Jolana Lipkova, et al.Experimental and Clinical Cardiology|April 18, 2013
Soluble ST2 levels in patients with cardiogenic and septic shock are not predictors of mortalityJiri Parenica, Jan Malaska, Jiri Jarkovsky, et al.Pageof 2